About Us
The Team
Advisors & Founders
Origins – Institute of Cancer Therapeutics (ICT) Bradford
What We Do
Our Approach
Technology Pipeline
Future Developments
Patients
Growth through Commercial Deals
Investment
Why invest?
Investment Case
News & media
News
Scientific Publications
Industry news
Contact Us
About Us
The Team
Advisors & Founders
Origins – Institute of Cancer Therapeutics (ICT) Bradford
What We Do
Our Approach
Technology Pipeline
Future Developments
Patients
Growth through Commercial Deals
Investment
Why invest?
Investment Case
News & media
News
Scientific Publications
Industry news
Contact Us
News & media
Latest From Incanthera
Incanthera Home
News & media
News
Latest from Incanthera
News
Select Year
2018
2017
2016
2015
2014
2013
2012
June 23rd, 2014
News
Company starts preclinical development of ICT03-Es5 agent